ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 107 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,910,356 | -28.9% | 194,933 | 0.0% | 0.01% | -27.3% |
| Q2 2023 | $5,499,060 | +64.0% | 194,933 | 0.0% | 0.01% | +57.1% |
| Q1 2023 | $3,352,848 | -14.6% | 194,933 | 0.0% | 0.01% | -22.2% |
| Q4 2022 | $3,925,951 | +19.4% | 194,933 | +28.4% | 0.01% | +12.5% |
| Q3 2022 | $3,289,000 | +40.1% | 151,853 | +81.8% | 0.01% | +33.3% |
| Q2 2022 | $2,347,000 | -39.1% | 83,526 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $3,854,000 | -45.1% | 83,526 | 0.0% | 0.01% | -38.5% |
| Q4 2021 | $7,021,000 | +204.7% | 83,526 | +141.5% | 0.01% | +160.0% |
| Q3 2021 | $2,304,000 | -32.9% | 34,580 | -46.5% | 0.01% | -28.6% |
| Q2 2021 | $3,436,000 | +854.4% | 64,580 | +678.1% | 0.01% | +600.0% |
| Q1 2021 | $360,000 | -16.5% | 8,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $431,000 | – | 8,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |